{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:25:16Z","timestamp":1759937116075},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.7759\/cureus.65945","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T13:34:40Z","timestamp":1722519280000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Severe Thrombocytopenia, Aseptic Meningitis, and Hepatitis Caused by Trimethoprim-Sulfamethoxazole: A Triple Threat"],"prefix":"10.7759","author":[{"given":"Srikanth R","family":"Kothapalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana","family":"Kesireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Trimethoprim Sulfamethoxazole","author":"Kemnic R","year":"2024","unstructured":"Kemnic R, Coleman M. Trimethoprim Sulfamethoxazole. StatPearls Publishing, Treasure Island; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.05.008","article-title":"Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders","volume":"52","author":"Kocak Z","year":"2006","unstructured":"Kocak Z, Hatipoglu CA, Ertem G, Kinikli S, Tufan A, Irmak H, Demiroz AP. Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders. J Infect. 2006, 52:e49-52. 10.1016\/j.jinf.2005.05.008","journal-title":"J Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","unstructured":"The use of the WHO-UMC system for standardised case causality assessment. (2018). Accessed. March 10, 2021: https:\/\/who-umc.org\/media\/164200\/who-umc-causality-assessment_new-logo.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George JN","year":"1998","unstructured":"George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998, 129:886-90. 10.7326\/0003-4819-129-11_part_1-199812010-00009","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427150-00007","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"van den Bemt PM","year":"2004","unstructured":"van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf. 2004, 27:1243-52. 10.2165\/00002018-200427150-00007","journal-title":"Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326100-00003","article-title":"Drug-induced myelosuppression: diagnosis and management","volume":"26","author":"Carey PJ","year":"2003","unstructured":"Carey PJ. Drug-induced myelosuppression: diagnosis and management. Drug Saf. 2003, 26:691-706. 10.2165\/00002018-200326100-00003","journal-title":"Drug Saf"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V82.9.2714.2714","article-title":"Acute thrombocytopenic purpura in relation to the use of drugs","volume":"82","author":"Kaufman DW","year":"1993","unstructured":"Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S. Acute thrombocytopenic purpura in relation to the use of drugs. Blood. 1993, 82:2714-8.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00590.x","article-title":"Hospitalization for serious blood and skin disorders following co-trimoxazole","volume":"43","author":"Myers MW","year":"1997","unstructured":"Myers MW, Jick H. Hospitalization for serious blood and skin disorders following co-trimoxazole. Br J Clin Pharmacol. 1997, 43:649-51. 10.1046\/j.1365-2125.1997.00590.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199409000-00019","article-title":"Treatment options in sulfamethoxazole-trimethoprim-induced thrombocytopenic purpura","volume":"87","author":"Herrington A","year":"1994","unstructured":"Herrington A, Mahmood A, Berger R. Treatment options in sulfamethoxazole-trimethoprim-induced thrombocytopenic purpura. South Med J. 1994, 87:948-50. 10.1097\/00007611-199409000-00019","journal-title":"South Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1963","article-title":"Life-threatening thrombocytopenia secondary to trimethoprim\/sulfamethoxazole","volume":"9","author":"Gaudel P","year":"2017","unstructured":"Gaudel P, Qavi AH, Basak P. Life-threatening thrombocytopenia secondary to trimethoprim\/sulfamethoxazole. Cureus. 2017, 9:e1963. 10.7759\/cureus.1963","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1568008033340243","article-title":"Drug-induced aseptic meningitis","volume":"3","author":"Nettis E","year":"2003","unstructured":"Nettis E, Calogiuri G, Colanardi MC, Ferrannini A, Tursi A. Drug-induced aseptic meningitis. Curr Drug Targets Immune Endocr Metabol Disord. 2003, 3:143-9. 10.2174\/1568008033340243","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02820-y","article-title":"Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim\/sulfamethoxazole: a case report","volume":"21","author":"van Asperdt JA","year":"2021","unstructured":"van Asperdt JA, De Moor RA. Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim\/sulfamethoxazole: a case report. BMC Pediatr. 2021, 21:345. 10.1186\/s12887-021-02820-y","journal-title":"BMC Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S425464","article-title":"Clinical characteristics, diagnosis, and management of aseptic meningitis induced by trimethoprim-sulfamethoxazole","volume":"16","author":"Fan Z","year":"2023","unstructured":"Fan Z, He Y, Sun W, Li Z, Zhu M, Wang C. Clinical characteristics, diagnosis, and management of aseptic meningitis induced by trimethoprim-sulfamethoxazole. Infect Drug Resist. 2023, 16:5825-32. 10.2147\/IDR.S425464","journal-title":"Infect Drug Resist"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1016\/S1665-2681(19)31956-8","article-title":"Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole","volume":"6","author":"Kouklakis G","year":"2007","unstructured":"Kouklakis G, Mpoumponaris A, Zezos P, et al.. Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole. Ann Hepatol. 2007, 6:63-5.","journal-title":"Ann Hepatol"},{"key":"ref16","article-title":"Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim","volume":"84","author":"Alberti-Flor JJ","year":"1989","unstructured":"Alberti-Flor JJ, Hernandez ME, Ferrer JP, Howell S, Jeffers L. Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. Am J Gastroenterol. 1989, 84:1577-9.","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.09.030","article-title":"Sulfamethoxazole-trimethoprim for pneumocystis pneumonia prophylaxis, causes of discontinuation and thrombocytopenia observed during administration: a single-center retrospective study","volume":"30","author":"Hashimoto M","year":"2024","unstructured":"Hashimoto M, Hiraiwa M, Uchitani K, Ueda M, Tanaka M, Nishiyama N, Miyashita N. Sulfamethoxazole-trimethoprim for pneumocystis pneumonia prophylaxis, causes of discontinuation and thrombocytopenia observed during administration: a single-center retrospective study. J Infect Chemother. 2024, 30:141-6. 10.1016\/j.jiac.2023.09.030","journal-title":"J Infect Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson E","year":"2005","unstructured":"Bj\u00f6rnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005, 42:481-9. 10.1002\/hep.20800","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.38207\/Jmcrcs20210062","article-title":"A case of trimethoprim-sulfamethoxazole-induced hepatitis","volume":"2","author":"Amoda OA","year":"2021","unstructured":"Amoda OA, Uwagbale E. A case of trimethoprim-sulfamethoxazole-induced hepatitis. J Med Case Rep Case Series. 2021, 2:10. 10.38207\/Jmcrcs20210062","journal-title":"J Med Case Rep Case Series"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080558","article-title":"Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole","volume":"67","author":"Chisholm-Burns MA","year":"2010","unstructured":"Chisholm-Burns MA, Patanwala AE, Spivey CA. Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole. Am J Health Syst Pharm. 2010, 67:123-7. 10.2146\/ajhp080558","journal-title":"Am J Health Syst Pharm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267190-a-case-of-severe-thrombocytopenia-aseptic-meningitis-and-hepatitis-caused-by-trimethoprim-sulfamethoxazole-a-triple-threat","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T13:35:12Z","timestamp":1722519312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267190-a-case-of-severe-thrombocytopenia-aseptic-meningitis-and-hepatitis-caused-by-trimethoprim-sulfamethoxazole-a-triple-threat"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.65945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}